These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 11524994)

  • 1. [ACE inhibitor plus glitazone. Insulin sensitizer, preventing diabetes?].
    MMW Fortschr Med; 2001 Jul; 143(30):52. PubMed ID: 11524994
    [No Abstract]   [Full Text] [Related]  

  • 2. [Primary prevention of diabetes mellitus by pharmacological intervention].
    Noda M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():100-8. PubMed ID: 12386980
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials.
    Abuissa H; Jones PG; Marso SP; O'Keefe JH
    J Am Coll Cardiol; 2005 Sep; 46(5):821-6. PubMed ID: 16139131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of arteriosclerosis with the insulin sensitizer pioglitazone. Early intervention in diabetic patients compensates "cell ignorance"].
    MMW Fortschr Med; 2002 May; 144(21):52-3. PubMed ID: 12134427
    [No Abstract]   [Full Text] [Related]  

  • 5. [ACE inhibitor even prevents diabetes. Sensational HOPE Study].
    MMW Fortschr Med; 1999 Sep; 141(39):6. PubMed ID: 10897977
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of type 2 diabetes.
    Yale JF
    Int J Clin Pract Suppl; 2000 Oct; (113):35-9. PubMed ID: 11965830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from randomized clinical trials.
    Phillips CO; Kashani A; Ko DK; Francis G; Krumholz HM
    Arch Intern Med; 2007 Oct; 167(18):1930-6. PubMed ID: 17923591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of inhibition of the renin-angiotensin system on development of type 2 diabetes mellitus (meta-analysis of randomized trials).
    Andraws R; Brown DL
    Am J Cardiol; 2007 Apr; 99(7):1006-12. PubMed ID: 17398202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on the rate of new-onset diabetes mellitus: a review and pooled analysis.
    McCall KL; Craddock D; Edwards K
    Pharmacotherapy; 2006 Sep; 26(9):1297-306. PubMed ID: 16945052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of effects of combined ACE inhibitor and low-dose thiazide diuretic with ACE inhibitor alone on insulin action in patients with hypertension and Type 2 diabetes: a double-blind crossover study.
    McLaughlin DM; Atkinson AB; Ennis CN; Browne J; Hunter SJ; Sheridan B; Bell PM
    Diabet Med; 2008 May; 25(5):631-4. PubMed ID: 18445178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An approach to heart failure and diabetes mellitus.
    Fonarow GC
    Am J Cardiol; 2005 Aug; 96(4A):47E-52E. PubMed ID: 16098844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in the treatment of patients with type 2 diabetes mellitus.
    Rosner MH; Okusa MD
    Arch Intern Med; 2003 May; 163(9):1025-9. PubMed ID: 12742799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Type 2 diabetes: blood pressure lowering to 135/75 mmHg reduces mortality].
    Einecke D
    MMW Fortschr Med; 2007 Sep; 149(38):18. PubMed ID: 18018407
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system].
    Boucek P
    Vnitr Lek; 2006 Sep; 52(9):791-6. PubMed ID: 17091602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral combination therapy with thiazolidinediones in type 2 diabetes.
    LaSalle JR; Cross LB
    Am J Manag Care; 2006 Nov; 12(14 Suppl):S369-81. PubMed ID: 17112324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.
    Strowig SM; Raskin P
    Diabetes Obes Metab; 2005 Nov; 7(6):633-41. PubMed ID: 16219007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic inflammation can cause type 2 diabetes].
    Sjöholm A; Nyström T
    Lakartidningen; 2004 May; 101(19):1716-21. PubMed ID: 15188586
    [No Abstract]   [Full Text] [Related]  

  • 20. [Interview with Prof. Peter Dominiak, Lübeck. "Risk of diabetes with antihypertensive drugs is clinically relevant" (interview by Dr. Angelika Bischoff)].
    Dominiak P
    MMW Fortschr Med; 2004 Dec; 146(51-52):51. PubMed ID: 15675248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.